Skip to main content
OpenTrials

Clinical trial condition

Hyperthyroidism

Explore clinical trials studying Hyperthyroidism. Study availability and eligibility vary by location and protocol.

218 public trials 58 recruiting studies
Refine in advanced search Browse all conditions

Hyperthyroidism trial results

Active, not recruiting

A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

NCT06812325

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Catalina Eye Care Tuscon, Arizona, United States
  • United Medical Research Institute Inglewood, California, United States
  • Orbital Plastics Newport Beach, California, United States
  • California Eye Specialists Medical Group INC Pasadena, California, United States
View all 64 locations
View Trial Details
Completed

A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

NCT05276063

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +20 more
Locations
  • Thrive Health Research Beverly Hills, California, United States
  • UC San Diego Health La Jolla, California, United States
  • UCLA Los Angeles, California, United States
  • Byers Eye Institute - Stanford University Palo Alto, California, United States
View all 30 locations
View Trial Details
Completed

TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study

NCT05002998

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • The Private Practice of Raymond Douglas, MD - Beverly Hills Beverly Hills, California, United States
  • USC Roski Eye Institute - Los Angeles Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
  • University of Colorado - Eye Center - PPDS Aurora, Colorado, United States
View all 28 locations
View Trial Details
Completed

An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301

NCT06179875

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Advancing Research International, LLC Los Angeles, California, United States
  • USC Eye Institute Los Angeles, California, United States
  • Advancing Research International, LLC Newport Beach, California, United States
  • Stanford Byers Eye Institute Palo Alto, California, United States
View all 45 locations
View Trial Details
Completed

A Safety, Tolerability, and Efficacy Study of Veligrotug (VRDN 001) in Participants With Thyroid Eye Disease (TED)

NCT05176639

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • University of Colorado - Department of Ophthalmology Aurora, California, United States
  • The Private Office of Raymond Douglas Beverly Hills, California, United States
  • USC Roski Eye Institute Los Angeles, California, United States
  • MACRO Trials, Inc. Los Angeles, California, United States
View all 53 locations
View Trial Details
Completed

A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)

NCT06384547

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • United Medical Research Institute Inglewood, California, United States
  • Advancing Research International, LLC Los Angeles, California, United States
  • Stanford Byers Eye Institute Palo Alto, California, United States
  • Cockerham Eye Consultants, PC San Diego, California, United States
View all 50 locations
View Trial Details
Completed

An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED)

NCT06021054

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Advancing Research International, LLC Los Angeles, California, United States
  • USC Roski Eye Institute Los Angeles, California, United States
  • Amy Patel Jain, MD Newport Beach, California, United States
  • Stanford Byers Eye Institute Palo Alto, California, United States
View all 57 locations
View Trial Details

Related conditions